Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

cGAS–STING signalling in cancer: striking a balance with chromosomal instability
Bruno Beernaert, Eileen E. Parkes
Biochemical Society Transactions (2023) Vol. 51, Iss. 2, pp. 539-555
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions
Nicholas Colangelo, Naamit K. Gerber, Ralph E. Vatner, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
cGAS Activation Accelerates the Progression of Autosomal Dominant Polycystic Kidney Disease
Miran Yoo, Jonathan C. Haydak, Evren U. Azeloglu, et al.
Journal of the American Society of Nephrology (2024) Vol. 35, Iss. 4, pp. 466-482
Closed Access | Times Cited: 5
mtDNA regulates cGAS-STING signaling pathway in adenomyosis
Kun Wang, Yi Wen, Xianyun Fu, et al.
Free Radical Biology and Medicine (2024) Vol. 216, pp. 80-88
Closed Access | Times Cited: 5
Immune microenvironment of cervical cancer and the role of IL-2 in tumor promotion
Leonardo Trujillo-Cirilo, Benny Weiss‐Steider, Carlos Adrián Vargas-Ángeles, et al.
Cytokine (2023) Vol. 170, pp. 156334-156334
Closed Access | Times Cited: 12
Nanocarrier-mediated modulation of cGAS-STING signaling pathway to disrupt tumor microenvironment
Sai Kiran S. S. Pindiprolu, Madhu Tanya Singh, Magham Sai Varshini, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges
Beilei Yue, Wenbo Gao, Jonathan F. Lovell, et al.
Essays in Biochemistry (2025) Vol. 69, Iss. 02
Open Access
STING Agonists and How to Reach Their Full Potential in Cancer Immunotherapy
Laura Gehrcken, Christophe Deben, Evelien Smits, et al.
Advanced Science (2025)
Open Access
Albumin-targeted oxaliplatin(iv) prodrugs bearing STING agonists
Martijn Dijkstra, Michael Gutmann, Mathias Gradl, et al.
Inorganic Chemistry Frontiers (2025)
Open Access
CIP2A coordinates phosphosignaling, mitosis, and the DNA damage response
Srikar G. Nagelli, Jukka Westermarck
Trends in cancer (2023) Vol. 10, Iss. 1, pp. 52-64
Open Access | Times Cited: 9
Make it STING: nanotechnological approaches for activating cGAS/STING as an immunomodulatory node in osteosarcoma
John O’Donoghue, Fiona E. Freeman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Chromosomal instability and inflammation: a catch-22 for cancer cells
Anouk van den Brink, Maria F. Suárez Peredo Rodríguez, Floris Foijer
Chromosome Research (2023) Vol. 31, Iss. 3
Open Access | Times Cited: 7
Genomic instability as a driver and suppressor of anti-tumor immunity
Marta Requesens, Floris Foijer, Hans W. Nijman, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Recent advancements in cGAS-STING activation, tumor immune evasion, and therapeutic implications
Md Saiful Islam, Mohammad Saiful Islam, Mst Rubaiat Nazneen Akhand, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 2
The entanglement of DNA damage and pattern recognition receptor signaling
Cindy T. Ha, Maha M. Tageldein, Shane M. Harding
DNA repair (2023) Vol. 133, pp. 103595-103595
Open Access | Times Cited: 4
Chromosomal Instability-Driven Cancer Progression: Interplay with the Tumour Microenvironment and Therapeutic Strategies
Siqi Zheng, Erika N. Guerrero, Floris Foijer
Cells (2023) Vol. 12, Iss. 23, pp. 2712-2712
Open Access | Times Cited: 4
Exploring the role of innate immunity in Cholangiocarcinoma: implications for prognosis, immune infiltration, and tumor metastasis
Wenhuan Sun, Jianrong Ge, Long Zhang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 11, pp. 3547-3565
Open Access | Times Cited: 1
The role of cGAS-STING signaling in the development and therapy of head and neck squamous cell carcinoma
Chengze Shao, Jiawen Chen, Qiang Bi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Targeting STING signaling for the optimal cancer immunotherapy
Yan Xu, Ying Xiong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Progress in understanding of relationship between inflammation and tumors
Zhao-Chun Chi
Shijie huaren xiaohua zazhi (2024) Vol. 32, Iss. 1, pp. 23-40
Open Access
Role of interferon dependent and independent signaling pathways: Implications in cancer
Sheila Spada, Anirban Ganguly
International review of cell and molecular biology (2024), pp. 153-162
Closed Access
Chromothripsis in cancer
Milena Simović, Aurélie Ernst
Nature reviews. Cancer (2024)
Closed Access
SKP2 inhibition activates tumor cell-intrinsic immunity by inducing DNA replication stress and genomic instability
Yuchong Peng, Xuli Qi, Liuyang Ding, et al.
British Journal of Cancer (2024) Vol. 132, Iss. 1, pp. 81-92
Closed Access
Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program
Noah M. Chernosky, Ilaria Tamagno, Kelsey L. Polak, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access
The cGAS-STING Pathway
Ulises O. Garcia-Lepe, Shane M. Harding
Elsevier eBooks (2024)
Closed Access
897-G SR-8541A, a small molecule inhibitor of ENPP1, enhances the effect of immune checkpoint inhibitors in a colorectal cancer model
Alexis Weston, Trason Thode, Serina Ng, et al.
(2023), pp. A1826-A1826
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top